← back to search

Antonio Gentilella

Universitat de Barcelona · ES
Area of research
Molecular Biology
Research interest
Research interests include Azacitidine, Decitabine, Myelodysplastic syndromes, CREB-binding protein, and Regulator.
h-index
citations
27
works
1
NIH funding
primary concept
email

Recent publications

Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis
Nature Communications 2021cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark van der Garde · Lund University1 papers (2021–2021) · 1 papers (2021–2021)Lurdes Zamora · Madrid Health Service1 papers (2021–2021)Johannes Zuber · Research Institute of Molecular Pathology1 papers (2021–2021)Carolina de la Torre · Universitat de Barcelona1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Nigel Brooks · CellCentric (United Kingdom)1 papers (2021–2021) · 1 papers (2021–2021)Jeannine Diesch · Monash University1 papers (2021–2021)Carolina Martinez- Herraez · Universitat de Barcelona1 papers (2021–2021)Matthias Muhar · ETH Zurich1 papers (2021–2021)Marcus Buschbeck · Université Claude Bernard Lyon 11 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Katharina S. Götze · German Cancer Research Center1 papers (2021–2021)